Fournier, A <br/><br/>
1-alpha-Hydroxyvitamin D3 derivatives in the treatment of renal bone diseases: justification and optimal modalities of administration.  [electronic resource] 

 -  Nephron  1995 
 - 254-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1660-8151 
<br/><br/><label>Standard No.: </label>10.1159/000188732  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Amyloidosis--drug therapy<br/>Animals<br/>Bone Diseases--complications<br/>Child<br/>Humans<br/>Hydroxycholecalciferols--therapeutic use<br/>Hyperparathyroidism--complications<br/>Models, Biological<br/>Osteomalacia--drug therapy<br/>Parathyroid Hormone--blood<br/>Renal Insufficiency--complications<br/>Uremia--complications